Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Withdrawn 1Unknown 1

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Pleural Effusion, Malignant 4Pleural Effusion 2Wound Infection 1Urinary Tract Infections 1Stomatitis 1Skin Neoplasms 1Sepsis 1Prostatic Neoplasms 1Pneumothorax 1Fever 1Esophageal Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

vandetanib 2Thoracoscopy 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Tenecteplase 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Afatinib 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pleural Effusion × Povidone-Iodine × Clear all
NCT02975921 2019-01-11

Betadine Pleurodesis Via Tunneled Pleural Catheters

Yale University

Phase 4 Withdrawn
Thoracic

Bronchiolitis Obliterans Syndrome, Pleural Effusion, Pleural Effusion, Malignant

NCT00430664 2007-02-02

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

PIMERIndia

Phase NA Unknown
100 enrolled
Thoracic

Pleural Effusion, Pneumothorax, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡